Investment AB Oresund (publ) Net debt/EBITDA
Cos'è Net debt/EBITDA di Investment AB Oresund (publ)?
Net debt/EBITDA di Investment AB Oresund (publ) è 1.01
Qual è la definizione di Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA di aziende nel Miscellaneous settore su LSE rispetto a Investment AB Oresund (publ)
Cosa fa Investment AB Oresund (publ)?
Investment AB Oresund is a publicly owned investment manager. Investment AB Oresund was founded in 1890 and is based in Stockholm, Sweden.
Aziende con net debt/ebitda simili a Investment AB Oresund (publ)
- Imperial Oil ha Net debt/EBITDA di 1.00
- Quantum Graphite ha Net debt/EBITDA di 1.00
- GOLO Mobile ha Net debt/EBITDA di 1.00
- Applied Energetics ha Net debt/EBITDA di 1.01
- Supernova Metals ha Net debt/EBITDA di 1.01
- Palatin Technologies ha Net debt/EBITDA di 1.01
- Investment AB Oresund (publ) ha Net debt/EBITDA di 1.01
- Tencent ha Net debt/EBITDA di 1.01
- Ryanair Plc ha Net debt/EBITDA di 1.01
- NOXXON Pharma NV ha Net debt/EBITDA di 1.02
- Appili Therapeutics Inc ha Net debt/EBITDA di 1.02
- Whitecap Resources ha Net debt/EBITDA di 1.02
- Smith & Wesson Brands ha Net debt/EBITDA di 1.02